Sławomir Januszewski Selected Research

Amyloid beta-Protein Precursor (Amyloid Protein Precursor)

12/2021	Post-Ischemic Neurodegeneration of the Hippocampus Resembling Alzheimer's Disease Proteinopathy.
2/2021	Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease.
1/2021	Brain Ischemia as a Prelude to Alzheimer's Disease.
6/2020	Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia.
4/2020	Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer's Disease to Brain Ischemia.
2/2020	Expression of the Tau Protein and Amyloid Protein Precursor Processing Genes in the CA3 Area of the Hippocampus in the Ischemic Model of Alzheimer's Disease in the Rat.
1/2020	Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.
1/2019	Amyloid pathology in the brain after ischemia.
1/2018	Platelets, lymphocytes and erythrocytes from Alzheimer's disease patients: the quest for blood cell-based biomarkers.
12/2016	Expression of Alzheimer's disease risk genes in ischemic brain degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sławomir Januszewski Research Topics

Disease

24	Brain Ischemia (Cerebral Ischemia) 06/2022 - 07/2002
24	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 09/2013
16	Ischemia 06/2022 - 01/2010
13	Dementia (Dementias) 06/2022 - 01/2008
9	Brain Injuries (Brain Injury) 06/2022 - 06/2016
8	Heart Arrest (Cardiac Arrest) 01/2017 - 02/2002
7	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2022 - 09/2013
3	Proteostasis Deficiencies 06/2022 - 01/2022
3	Neuroinflammatory Diseases 06/2022 - 01/2021
2	Ischemic Stroke 06/2022 - 01/2020
2	Atrophy 06/2022 - 12/2013
2	Infarction (Infarctions) 01/2022 - 09/2003
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2020
2	Reperfusion Injury 01/2020 - 01/2010
2	Seizures (Absence Seizure) 06/2015 - 01/2015
1	Brain Edema (Cerebral Edema) 01/2022
1	Dysbiosis 02/2020
1	Neoplasms (Cancer) 02/2020
1	Inflammation (Inflammations) 01/2020
1	Epilepsy (Aura) 10/2019
1	Drug Resistant Epilepsy 10/2019
1	Tauopathies 10/2018
1	Amyloid Plaque 01/2018
1	Cognitive Dysfunction 01/2017
1	Wounds and Injuries (Trauma) 06/2016
1	Leukoaraiosis 01/2008
1	Myocardial Infarction 09/2003

Drug/Important Bio-Agent (IBA)

22	Amyloid (Amyloid Fibrils)IBA 06/2022 - 01/2008
20	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
18	tau Proteins (tau Protein)IBA 06/2022 - 12/2013
10	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 12/2021 - 12/2016
10	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 02/2021 - 09/2013
7	Presenilin-1IBA 02/2021 - 01/2015
6	Peptides (Polypeptides)IBA 01/2018 - 01/2010
4	CurcuminIBA 01/2022 - 01/2015
3	Presenilin-2IBA 01/2021 - 02/2016
3	EnzymesIBA 02/2020 - 12/2013
3	Caspase 3 (Caspase-3)IBA 01/2019 - 01/2016
3	PresenilinsIBA 06/2016 - 01/2015
2	Free RadicalsIBA 01/2022 - 07/2002
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2019 - 01/2016
1	Neuroprotective AgentsIBA 06/2022
1	HydrogenIBA 06/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	AntioxidantsIBA 01/2021
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2021
1	myricetinIBA 01/2021
1	PolyphenolsIBA 02/2020
1	PrebioticsIBA 01/2020
1	Amyloidogenic ProteinsIBA 01/2020
1	CaspasesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	ApolipoproteinsIBA 06/2016
1	Pentylenetetrazole (Metrazol)IBA 06/2015
1	salicylhydroxamic acid (SHAM)IBA 06/2015
1	gamma-Aminobutyric Acid (GABA)IBA 01/2015
1	Carisoprodol (Soma)FDA LinkGeneric 09/2013
1	Protein AggregatesIBA 09/2013
1	Amyloid beta-PeptidesIBA 01/2010
1	Horseradish PeroxidaseIBA 01/2010
1	Bosentan (Tracleer)FDA Link 09/2003
1	LeptinIBA 09/2003
1	Endothelin Receptor AntagonistsIBA 09/2003
1	Endothelin Receptors (Endothelin Receptor)IBA 09/2003
1	Dopamine (Intropin)FDA LinkGeneric 01/2003

Therapy/Procedure

2	Therapeutics 06/2022 - 01/2020
2	Resuscitation 01/2017 - 02/2002
1	Ketogenic Diet 10/2019